Ernst M, Versluis J, Valk P, Bierings M, Tamminga R, Hooimeijer L
Hemasphere. 2025; 9(1):e70057.
PMID: 39822584
PMC: 11735945.
DOI: 10.1002/hem3.70057.
Cazzola M, Malcovati L
Haematologica. 2024; 110(2):312-329.
PMID: 39445412
PMC: 11788631.
DOI: 10.3324/haematol.2023.284947.
Kansal R
Genes (Basel). 2024; 15(7).
PMID: 39062641
PMC: 11276294.
DOI: 10.3390/genes15070863.
Jayne N, Liang Z, Lim D, Chen P, Diaz C, Arimoto K
Blood Adv. 2024; 8(10):2410-2423.
PMID: 38513139
PMC: 11112616.
DOI: 10.1182/bloodadvances.2023011484.
Arai H, Matsui H, Chi S, Utsu Y, Masuda S, Aotsuka N
Int J Mol Sci. 2024; 25(1).
PMID: 38203823
PMC: 10779750.
DOI: 10.3390/ijms25010652.
RUNX1 is required in granulocyte-monocyte progenitors to attenuate inflammatory cytokine production by neutrophils.
Zezulin A, Yen D, Ye D, Howell E, Bresciani E, Diemer J
Genes Dev. 2023; 37(13-14):605-620.
PMID: 37536952
PMC: 10499021.
DOI: 10.1101/gad.350418.123.
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Homan C, Drazer M, Yu K, Lawrence D, Feng J, Arriola-Martinez L
Blood Adv. 2023; 7(20):6092-6107.
PMID: 37406166
PMC: 10582382.
DOI: 10.1182/bloodadvances.2023010045.
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.
Zerella J, Homan C, Arts P, Brown A, Scott H, Hahn C
Front Oncol. 2023; 13:1183318.
PMID: 37377909
PMC: 10291195.
DOI: 10.3389/fonc.2023.1183318.
An Old Dog Has a New Trick: Somatic Exonic Deletions in RUNX1 Are Frequent in AML.
Chakraborty J, Stengel K
Clin Cancer Res. 2023; 29(15):2742-2744.
PMID: 37289016
PMC: 10525005.
DOI: 10.1158/1078-0432.CCR-23-1065.
Transcription factors in megakaryocytes and platelets.
Yuan H, Liu Y, Zhang J, Dong J, Zhao Z
Front Immunol. 2023; 14:1140501.
PMID: 36969155
PMC: 10034027.
DOI: 10.3389/fimmu.2023.1140501.
Germline variants in paediatric patients in a French specialised centre.
Liu C, Ballerini P, Nguyen G, Mincheva Z, Copin B, Bouslama B
EJHaem. 2023; 4(1):145-152.
PMID: 36819173
PMC: 9928638.
DOI: 10.1002/jha2.594.
Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26.
Homan C, Scott H, Brown A
Blood. 2023; 141(13):1533-1543.
PMID: 36626254
PMC: 10651873.
DOI: 10.1182/blood.2022017735.
A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies.
Lee B, Zhou Y, Bresciani E, Ozkaya N, Dulau-Florea A, Carrington B
Blood. 2022; 141(3):231-237.
PMID: 36322931
PMC: 9936307.
DOI: 10.1182/blood.2022018193.
Beyond Pathogenic Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies.
Forster A, Decker M, Schlegelberger B, Ripperger T
Cancers (Basel). 2022; 14(14).
PMID: 35884491
PMC: 9320507.
DOI: 10.3390/cancers14143431.
Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency.
Jalagadugula G, Mao G, Goldfinger L, Wurtzel J, Del Carpio-Cano F, Lambert M
Blood Adv. 2022; 6(17):5100-5112.
PMID: 35839075
PMC: 9631641.
DOI: 10.1182/bloodadvances.2021006945.
Validation and clinical application of transactivation assays for RUNX1 variant classification.
Decker M, Agarwal A, Benneche A, Churpek J, Duployez N, Duvall A
Blood Adv. 2022; 6(11):3195-3200.
PMID: 35026845
PMC: 9198940.
DOI: 10.1182/bloodadvances.2021006161.
To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.
Avagyan S, Brown A
J Clin Invest. 2021; 131(17).
PMID: 34623329
PMC: 8409576.
DOI: 10.1172/JCI152464.